Lista de obras -

Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).

artículo científico publicado en 2017

Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers

scientific article published on 29 August 2019

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy.

artículo científico publicado en 2018

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

artículo científico publicado en 2017

Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models

scientific article published on 08 March 2019

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

article by Akihiko Yoshimura et al published 5 November 2018 in BMC Cancer

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

artículo científico publicado en 2016

Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells

artículo científico publicado en 2009

IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment

artículo científico publicado en 2015

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

artículo científico publicado en 2017

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

artículo científico publicado en 2015

Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer

scientific article published on 30 October 2018

Oncological and Reproductive Outcomes of Abdominal Radical Trachelectomy

artículo científico publicado en 2020

PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo

artículo científico publicado en 2017

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination

artículo científico publicado en 2017

Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary

artículo científico publicado en 2014

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

artículo científico publicado en 2016

Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases

artículo científico publicado en 2017

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

artículo científico publicado en 2018

Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells

artículo científico publicado en 2016

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

artículo científico publicado en 2018

The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice

artículo científico publicado en 2016

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.

artículo científico publicado en 2015

The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations

artículo científico publicado en 2019

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

artículo científico publicado en 2020

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

artículo científico publicado en 2015

miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression

artículo científico publicado en 2013

Lista de obras de

Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).

Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy.

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: investigations on pregnant and non-pregnant experimental models

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells

Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells

IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment

In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer

Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer

Oncological and Reproductive Outcomes of Abdominal Radical Trachelectomy

PM01183 inhibits myeloid-derived suppressor cells in vitro and in vivo

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination

Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.

The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations

The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression